{"id":509,"date":"2018-09-10T10:26:56","date_gmt":"2018-09-10T14:26:56","guid":{"rendered":"http:\/\/web.colby.edu\/ch141\/?p=509"},"modified":"2018-09-10T10:36:32","modified_gmt":"2018-09-10T14:36:32","slug":"can-mrna-disrupt-the-drug-industry","status":"publish","type":"post","link":"https:\/\/web.colby.edu\/ch141\/2018\/09\/10\/can-mrna-disrupt-the-drug-industry\/","title":{"rendered":"Can mRNA disrupt the drug industry?"},"content":{"rendered":"<p><b>Used by all living things to make proteins,<\/b> messenger RNA is one of the least explored frontiers of drug discovery. Moderna Therapeutics, and an increasing number of similarly well-funded biotech firms, is built on the promise that mRNA can be turned into a powerful treatment for genetic diseases, cancer, infectious diseases, and more. But turning mRNA into a drug is far from trivial, and companies have kept their technology largely under wraps. Now, Moderna is offering a glimpse of its massive research engine. Read on to learn how researchers are trying to move mRNA out of the lab and into the clinic. \u00a0&#8211;<a href=\"https:\/\/cen.acs.org\/business\/start-ups\/mRNA-disrupt-drug-industry\/96\/i35\"> Read more.<\/a><\/p>\n<p>Reference: Chemical &amp; Engineering News, SEPTEMBER 3, 2018 | APPEARED IN VOLUME 96, ISSUE 35<\/p>\n<p><strong>Resources:<\/strong> \u00a0This video was also posted by the American Chemical Society&#8230;<\/p>\n<p><iframe loading=\"lazy\" title=\"Genetically Modified Humans? CRISPR\/Cas 9 Explained\" width=\"500\" height=\"281\" src=\"https:\/\/www.youtube.com\/embed\/5gQGWJraptU?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Used by all living things to make proteins, messenger RNA is one of the least explored frontiers of drug discovery. Moderna Therapeutics, and an increasing number of similarly well-funded biotech firms, is built on the promise that mRNA can be turned into a powerful treatment for genetic diseases, cancer, infectious diseases, and more. But turning [&hellip;]<\/p>\n","protected":false},"author":184,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"ngg_post_thumbnail":0,"footnotes":""},"categories":[135920],"tags":[],"_links":{"self":[{"href":"https:\/\/web.colby.edu\/ch141\/wp-json\/wp\/v2\/posts\/509"}],"collection":[{"href":"https:\/\/web.colby.edu\/ch141\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/web.colby.edu\/ch141\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/web.colby.edu\/ch141\/wp-json\/wp\/v2\/users\/184"}],"replies":[{"embeddable":true,"href":"https:\/\/web.colby.edu\/ch141\/wp-json\/wp\/v2\/comments?post=509"}],"version-history":[{"count":2,"href":"https:\/\/web.colby.edu\/ch141\/wp-json\/wp\/v2\/posts\/509\/revisions"}],"predecessor-version":[{"id":513,"href":"https:\/\/web.colby.edu\/ch141\/wp-json\/wp\/v2\/posts\/509\/revisions\/513"}],"wp:attachment":[{"href":"https:\/\/web.colby.edu\/ch141\/wp-json\/wp\/v2\/media?parent=509"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/web.colby.edu\/ch141\/wp-json\/wp\/v2\/categories?post=509"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/web.colby.edu\/ch141\/wp-json\/wp\/v2\/tags?post=509"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}